ID

29597

Description

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00722332

Lien

https://clinicaltrials.gov/show/NCT00722332

Mots-clés

Versions (1)
  1. 10/04/18 10/04/18 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

10 aprile 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatitis B NCT00722332

Anglais

Eligibility Hepatitis B NCT00722332

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
hbsag-positive candidates for hbv-related liver transplant
Description

Hepatitis B surface antigen positive | Transplantation of liver Relationship Hepatitis B Virus Anticipated

Type de données

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2,1]
C0023911
UMLS CUI [2,2]
C0439849
UMLS CUI [2,3]
C0019169
UMLS CUI [2,4]
C3840775
treatment with antiviral therapy before transplantation as per treating physician's recommendation. (note: it is expected that most patients will receive lamivudine or adefovir dipivoxil pre-transplant. in the case of antiviral resistance, an effective alternative antiviral agent(s) must be used.)
Description

Antiviral Therapy Before Transplantation | Lamivudine | adefovir dipivoxil

Type de données

boolean

Alias
UMLS CUI [1,1]
C0280274
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0040732
UMLS CUI [2]
C0209738
UMLS CUI [3]
C0540694
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
multi-organ transplantation recipients
Description

Recipient Organ Transplantation multiple

Type de données

boolean

Alias
UMLS CUI [1,1]
C1709854
UMLS CUI [1,2]
C0029216
UMLS CUI [1,3]
C0439064
liver re-transplantation except for primary non-function
Description

Liver retransplantation | Exception primary failure of transplanted liver

Type de données

boolean

Alias
UMLS CUI [1]
C4087552
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C2728977
presence of a hepatoma (larger than 5.0 cm as a solitary node) or 2 to 3 multi-focal nodes (larger than 3.0 cm each) (milan criteria) based on information available at baseline visit (ct scan, mri).
Description

Hepatoma | Size Node Solitary | Size Nodes Multifocal | CT scan | MRI

Type de données

boolean

Alias
UMLS CUI [1]
C0023903
UMLS CUI [2,1]
C0456389
UMLS CUI [2,2]
C0024204
UMLS CUI [2,3]
C0205171
UMLS CUI [3,1]
C0456389
UMLS CUI [3,2]
C0024204
UMLS CUI [3,3]
C0205292
UMLS CUI [4]
C0040405
UMLS CUI [5]
C0024485
patients requiring an olt (orthotopic liver transplant)due to fulminant hepatitis b
Description

Orthotopic liver transplant Due to Hepatitis B

Type de données

boolean

Alias
UMLS CUI [1,1]
C0400447
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0019163
olt patients receiving a liver graft from a donor that is positive for hbsag
Description

Orthotopic liver transplant | Liver graft Donor Hepatitis B surface antigen positive

Type de données

boolean

Alias
UMLS CUI [1]
C0400447
UMLS CUI [2,1]
C1720613
UMLS CUI [2,2]
C0013018
UMLS CUI [2,3]
C0149709
patients using interferon pre-transplant (as interferon cannot be used post-transplant)
Description

Interferon prior to Transplantation

Type de données

boolean

Alias
UMLS CUI [1,1]
C3652465
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0040732
history of iga (immunoglobulin a) deficiency
Description

Immunoglobulin A deficiency

Type de données

boolean

Alias
UMLS CUI [1]
C0162538
history of hypersensitivity to blood products.
Description

Hypersensitivity Blood product

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0456388
hiv or hcv positive
Description

HIV Seropositivity | Hepatitis C virus Positive

Type de données

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2,1]
C0220847
UMLS CUI [2,2]
C1514241
use of an investigational product, or participation in another clinical trial during the course of the study (with the exception of quality-of-life or repository studies)
Description

Investigational New Drugs | Study Subject Participation Status | Exception Quality of life Clinical Trials | Exception Repository Clinical Trials

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C2348568
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0034380
UMLS CUI [3,3]
C0008976
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C3847505
UMLS CUI [4,3]
C0008976
pregnancy or planned pregnancy during the course of the study
Description

Pregnancy | Pregnancy, Planned

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
Retour au début de la page

Similar models

Eligibility Hepatitis B NCT00722332

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Hepatitis B surface antigen positive | Transplantation of liver Relationship Hepatitis B Virus Anticipated
Item
hbsag-positive candidates for hbv-related liver transplant
boolean
C0149709 (UMLS CUI [1])
C0023911 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C0019169 (UMLS CUI [2,3])
C3840775 (UMLS CUI [2,4])
Antiviral Therapy Before Transplantation | Lamivudine | adefovir dipivoxil
Item
treatment with antiviral therapy before transplantation as per treating physician's recommendation. (note: it is expected that most patients will receive lamivudine or adefovir dipivoxil pre-transplant. in the case of antiviral resistance, an effective alternative antiviral agent(s) must be used.)
boolean
C0280274 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0040732 (UMLS CUI [1,3])
C0209738 (UMLS CUI [2])
C0540694 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Recipient Organ Transplantation multiple
Item
multi-organ transplantation recipients
boolean
C1709854 (UMLS CUI [1,1])
C0029216 (UMLS CUI [1,2])
C0439064 (UMLS CUI [1,3])
Liver retransplantation | Exception primary failure of transplanted liver
Item
liver re-transplantation except for primary non-function
boolean
C4087552 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C2728977 (UMLS CUI [2,2])
Hepatoma | Size Node Solitary | Size Nodes Multifocal | CT scan | MRI
Item
presence of a hepatoma (larger than 5.0 cm as a solitary node) or 2 to 3 multi-focal nodes (larger than 3.0 cm each) (milan criteria) based on information available at baseline visit (ct scan, mri).
boolean
C0023903 (UMLS CUI [1])
C0456389 (UMLS CUI [2,1])
C0024204 (UMLS CUI [2,2])
C0205171 (UMLS CUI [2,3])
C0456389 (UMLS CUI [3,1])
C0024204 (UMLS CUI [3,2])
C0205292 (UMLS CUI [3,3])
C0040405 (UMLS CUI [4])
C0024485 (UMLS CUI [5])
Orthotopic liver transplant Due to Hepatitis B
Item
patients requiring an olt (orthotopic liver transplant)due to fulminant hepatitis b
boolean
C0400447 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0019163 (UMLS CUI [1,3])
Orthotopic liver transplant | Liver graft Donor Hepatitis B surface antigen positive
Item
olt patients receiving a liver graft from a donor that is positive for hbsag
boolean
C0400447 (UMLS CUI [1])
C1720613 (UMLS CUI [2,1])
C0013018 (UMLS CUI [2,2])
C0149709 (UMLS CUI [2,3])
Interferon prior to Transplantation
Item
patients using interferon pre-transplant (as interferon cannot be used post-transplant)
boolean
C3652465 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0040732 (UMLS CUI [1,3])
Immunoglobulin A deficiency
Item
history of iga (immunoglobulin a) deficiency
boolean
C0162538 (UMLS CUI [1])
Hypersensitivity Blood product
Item
history of hypersensitivity to blood products.
boolean
C0020517 (UMLS CUI [1,1])
C0456388 (UMLS CUI [1,2])
HIV Seropositivity | Hepatitis C virus Positive
Item
hiv or hcv positive
boolean
C0019699 (UMLS CUI [1])
C0220847 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
Investigational New Drugs | Study Subject Participation Status | Exception Quality of life Clinical Trials | Exception Repository Clinical Trials
Item
use of an investigational product, or participation in another clinical trial during the course of the study (with the exception of quality-of-life or repository studies)
boolean
C0013230 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0034380 (UMLS CUI [3,2])
C0008976 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C3847505 (UMLS CUI [4,2])
C0008976 (UMLS CUI [4,3])
Pregnancy | Pregnancy, Planned
Item
pregnancy or planned pregnancy during the course of the study
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial